NCT07257822Active, not recruiting
The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes
The Digital Diabetes Patient Reminder (DIPAR) Tool to Improve Clinical Outcomes and Process of Management in Adults With Type 2 Diabetes: A Proof-of-Concept Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 19 Feb 2026
Brief summary (registry, in English)
Digital health tools may present an opportunity to address these challenges by enhancing care delivery, improving patient engagement, and facilitating better disease management for chronic diseases such as type 2 diabetes mellitus (T2DM). This primary objective of this randomized controlled trial is to evaluate whether the Diabetes Digital Patient Reminder (DIPAR), embedded in patient portal, can increase the proportion of T2DM patients who have their albuminuria measured at least once annually by either a general practitioner (GP) or a diabetes specialist, as documented in their hospital medical records (EMD), thereby reflecting active monitoring of diabetes-related parameters.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 24 Sept 2025
- Start date
- 6 Oct 2025
- Primary completion date
- Jun 2027
- Lead sponsor
- KU Leuven
- Diseases
- Type 2 diabetes
- NCT number
- NCT07257822
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 6 Oct 2025 to the primary completion date, Jun 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Are unable to use a mobile phone because of mental or cognitive impairment;
Other
- Participant is pregnant or hospitalized at the time of recruitment;
- Deemed ineligible by the treating physicians.
Who the study is looking for
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures;
- Adults 18 years or older;
- Treated and followed-up for Type 2 diabetes at the department of endocrinology at the participating hospitals;
- Patients with (the ability to access) the MyNexuz patient portal;
- Patients with the ability to understand Dutch, French or English.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital of UZ Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Unknown status |
| Regional Hospital of Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.